ADVERSARIAL DRUG DISCOVERY
• PROTEOMICS
• LONGEVITY
• SYNBIO
• CAMBRIDGE
• VENTURE
• INVESTMENT
• BIOSCIENCE
• AI
• ML
• CODE
• DATA PIPELINES
• BIOTECH FUNDING
• DEEP TECH
• ADVANCING SCIENCE
• EPISODES
EP. 004

This week, The Biotech Thesis explores the cutting edge of human longevity research with Dr. Lila Verma, a pioneer in mapping the human proteome. Dr. Verma discusses her team’s latest breakthroughs in high-throughput protein analysis and unveils new methods that could unlock resilient cellular pathways against age-related decline. We delve into computational techniques for sifting signal from noise in multiomic datasets—highlighting both the promise and limitations of bioinformatics today. The conversation also grapples with ethical considerations at the frontier of synthetic biology, including the need for scientific rigor in an era of hype and capital abundance. We end on a deep-dive into how Cambridge’s academic ecosystem continues to foster paradigm-shifting innovation in longevity and therapeutics.


